BDBM380206 5-(adamantan-1-yl)-1- methyl-N-[4-(4-oxo-3,4- dihydrophthalazin-1- yl)phenyl]-1H-pyrazole- 3-carboxamide::US9926282, Example 201

SMILES Cn1nc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)cc1C12CC3CC(CC(C3)C1)C2

InChI Key InChIKey=HDKOQZTWSMTKPW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 380206   

TargetRho-associated protein kinase 2(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 380206BDBM380206(5-(adamantan-1-yl)-1- methyl-N-[4-(4-oxo-3,4- dihy...)
Affinity DataIC50: 100nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2020
Entry Details
US Patent

TargetRho-associated protein kinase 1(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 380206BDBM380206(5-(adamantan-1-yl)-1- methyl-N-[4-(4-oxo-3,4- dihy...)
Affinity DataIC50: 100nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2020
Entry Details
US Patent